ERBB2 and breast carcinoma: Although the mechanism of the association between OPRM1 hypermethylation and ER/PR-negative status remains to be investigated, as does the association between OPRM1 hypermethylation in PBL DNA and HER-2 negative status, our results may provide new ideas for the treatment of breast cancer patients through further studies on epigenetic regulation.